Skip to content
HHair Transplant SourceIndependent education

Graft Storage Solutions Compared: HypoThermosol and Alternatives

By Editorial TeamUpdated Jul 10, 2026 7 min read
Hair transplant graft storage containers with chilled holding solution
Hair transplant graft storage containers with chilled holding solution

Graft storage solution is the most under-discussed instrument decision in hair transplant practice. Every other major instrument — punches, blades, Choi pens, microscopes — gets dedicated marketing attention. The fluid the grafts sit in for hours between extraction and implantation often does not. Yet the storage solution affects graft survival as much as the extraction tools that came before it, and the cost differential between options is small relative to the survival impact in long cases.

This article walks through the three most common solutions, what the data supports about each, and how to choose for your case mix.

What graft storage actually does

Once a follicular unit is extracted, it loses its connection to blood supply. Cells begin metabolic damage immediately. Storage solution serves three protective functions:

  1. Hydration. Prevents cell desiccation at the surface and within the graft.
  2. Metabolic support. Provides the buffered ionic environment cells need at low temperature.
  3. Cooling medium. Holds the chilled temperature that slows metabolism.

A poor storage solution fails one or more of these functions. The most visible failure is desiccation — grafts that visibly dry out at the surface during sorting and pre-implantation hold. Less visible failures include osmotic stress (cells damaged by ionic imbalance) and metabolic exhaustion (cells dying from lack of substrate at extended hold times).

The variables that most affect graft survival broadly — extraction transection, time-out-of-body, graft handling — are documented in graft survival rate in FUE and DHI. Storage solution choice is one of these levers, downstream of pacing and upstream of placement.

The three commonly used solutions

Solution Mechanism Cost per 100 mL Use case
HypoThermosol-FRS Buffered hypothermic preservation, antioxidants €40–€80 Premium standard, long cases
Lactated Ringer's Buffered electrolyte solution €5–€15 Mid-tier, moderate cases
0.9% Saline Simple isotonic solution €2–€5 Budget, short cases only

The premium-to-budget cost differential is real but the per-case impact is bounded — a typical case uses 50–100 mL total, so the maximum cost difference between premium and budget is €30–€80 per case. Compared to the marketing-quoted savings on cheaper consumables, the storage solution is one of the cheapest places to optimise on quality.

What the evidence supports

Published clinical series and laboratory studies converge on a similar pattern:

  • At ≤2 hours out-of-body, all three solutions produce comparable survival in trained-team cases.
  • At 3–4 hours, HypoThermosol shows a 5–10% survival advantage over saline in published comparisons. Lactated Ringer's lands in between.
  • Beyond 5 hours, the gap widens. HypoThermosol-stored grafts retain significantly better viability than saline-stored grafts, though all solutions show declining survival.

The implication: for short cases (under 2,500 grafts in a single session, completed in under 5 hours of total out-of-body time), saline-stored grafts perform similarly to premium-stored grafts. For long cases (4,000+ grafts, sessions exceeding 5 hours), premium storage matters meaningfully.

Operational discipline around storage

The storage solution is one variable. The protocol around it matters more.

Temperature consistency. 4°C is the target. Warmer storage accelerates damage; the clinic that lets containers warm to room temperature between batches loses survival regardless of solution choice. A working clinic uses chilled storage containers and monitors temperature with thermometers.

Refresh cycles. Holding solution accumulates cellular debris and degrades over the course of a long case. Most clinics refresh storage solution every 60–90 minutes during long cases. Premium solutions buffer better against this degradation; budget solutions degrade faster.

Container hygiene. Sterile, single-use storage containers (or rigorously sterilised reusable containers) are baseline. Cross-contamination between containers from different patients is a never-event but does happen in undisciplined clinics.

Time logging. Each batch of grafts has an extraction time. The protocol allows up to a documented out-of-body limit (typically 4 hours premium, less for saline). Grafts approaching the limit are prioritised for placement. Without time logging, the limit is theoretical.

When to invest in premium storage

Three scenarios where the upgrade from saline/Ringer's to HypoThermosol pays back clinically:

Scenario 1: Routine large cases (3,500+ grafts). Long sessions exceed the safe window for budget solutions. Premium storage protects survival in the last 1,000+ grafts placed.

Scenario 2: International patient cases. Patients flying in often have one shot at a successful procedure. Even a 5–8% survival advantage compounds into meaningfully better year-12 outcomes that drive review velocity and reputation.

Scenario 3: Repair cases over previous transplants. Limited donor reserve makes every graft count. The premium storage cost (€20–€60 per case) is trivial relative to the donor cost of replacing failed grafts in a repair case.

For predominantly small (under 2,000 grafts) routine cases with strong pacing discipline, saline or lactated Ringer's at proper temperature with disciplined refresh cycles produces acceptable outcomes.

Procurement notes

HypoThermosol-FRS is sold by major medical preservation suppliers (BioLife Solutions in the US; multiple European distributors). Lead times are typically 1–2 weeks; stock 2–3 months of supply at all times. Storage requires standard refrigeration; shelf life is typically 12 months from manufacture.

Lactated Ringer's and saline are commodity items available through standard medical suppliers. The supplier evaluation framework — covered in evaluating hair transplant equipment suppliers — applies; stick with reputable medical suppliers for any IV-grade solution.

The wider instrument procurement context is in hair transplant instruments: a complete practitioner's guide.

What patients should not be told

Three claims that show up in marketing but exceed what the evidence supports:

  • "Our exclusive proprietary solution gives 99% graft survival." Proprietary solutions without published evidence are marketing claims. Be sceptical.
  • "We use FDA-approved storage solution." HypoThermosol is regulated; saline is regulated; the regulatory status alone is not a quality signal.
  • "Standard saline is just as good as anything else." Defensible for short cases; not defensible for long cases.

The honest framing is what we use throughout this site: name the solution, explain the trade-offs, document what the evidence supports, leave room for clinical judgment.

What this means in practice

A working hair transplant clinic should make a deliberate choice about storage solution based on its case mix. Pure-routine clinics doing predominantly short cases can defensibly use saline or lactated Ringer's with strict pacing. Clinics doing mixed cases including long sessions or international patients should standardise on HypoThermosol or equivalent premium solution. Mixed clinics can stock both and select per case profile, with documented selection criteria.

Whichever solution the clinic uses, the protocol around it determines outcomes more than the solution itself. Temperature monitoring, refresh cycles, time logging, container hygiene — these compound across cases. The clinic that audits its protocol every quarter improves its outcomes; the clinic that buys premium solution and runs sloppy protocol still produces inconsistent results.

For the broader survival-driving variables, see graft survival rate in FUE and DHI. For technique-level placement detail, see FUE hair transplant technique, step by step and DHI hair transplant step by step.

Storage solution and team training

The team handling grafts needs explicit training on solution protocol — not just instruction in passing. The training pathway covered in training a hair transplant team: a 12-week internal programme includes graft handling discipline as a dedicated module. Three things the team must internalise:

Refresh timing. When solution gets refreshed, who does it, and how the team logs it. Without explicit training, refresh cycles become inconsistent across operators.

Temperature checks. Reading the storage container thermometer is an action item, not an assumption. Trained technicians check temperature at the start of each batch, log the reading, and escalate if temperature drifts above 6°C.

Substitution protocol. What to do if the planned solution runs out mid-case. The right answer is having backup stock — the wrong answer is silently substituting whatever's available. Document the substitution protocol in the SOP set; a working SOP example is in standard operating procedures for a hair transplant clinic.

The team that runs storage protocol consistently produces consistent month-12 outcomes. The team that improvises produces variable outcomes the surgeon often cannot trace back to the storage step.

In short: HypoThermosol for serious work; saline only for short, well-paced cases. The cost differential is small; the survival differential in long cases is not.

Frequently asked questions

What's HypoThermosol?

HypoThermosol-FRS is a hypothermic preservation solution designed for cell and tissue storage at 2–8°C. It contains buffered electrolytes, antioxidants, and components that reduce metabolic stress in cooled tissue. It's the most widely studied solution for hair graft storage and the standard in serious clinical practice.

Can I use saline instead of HypoThermosol?

For short cases (under 3 hours total out-of-body time), saline produces comparable survival in published series. For longer cases, saline shows measurably worse outcomes. The cost difference is small (€20–€60 per case); for long cases the survival impact is not worth the saving.

What temperature should grafts be stored at?

4°C is the standard target. Warmer (room temperature) accelerates metabolic damage. Colder (below 0°C) risks ice crystal formation. A reliable refrigerated container with thermometer monitoring is part of the basic kit. The wider time-out-of-body discipline is covered in graft handling protocol.

How long can grafts safely sit in solution?

Survival declines progressively after 2–3 hours and noticeably after 4–5 hours regardless of solution. HypoThermosol extends the usable window slightly compared to saline, but does not eliminate the time effect. Pacing the case to avoid grafts holding longer than 4 hours is the operational discipline.

Is lactated Ringer's better than saline?

Marginally. Lactated Ringer's contains additional electrolytes that better support tissue homeostasis than plain saline. The clinical advantage is small in short cases. For premium results in long cases, HypoThermosol still outperforms both.

Should we add additives to saline?

Some clinics add buffer agents, ATP, or growth factors to saline to approximate HypoThermosol's properties. The clinical evidence for these custom mixes is weaker than for established preservation solutions. Buy validated solutions rather than mixing your own; the cost of mistakes exceeds the cost saving.

How much HypoThermosol does a typical case use?

A 2,500-graft case typically uses 50–100 mL of holding solution across multiple containers and refresh cycles. HypoThermosol-FRS retail price runs €40–€80 per 100 mL bottle from medical suppliers. Per-case cost: €20–€80 depending on case size and refresh frequency.

Does the storage container matter?

Yes. A clean, sterile, chilled container with a known temperature is the bar. Petri dishes vs. specialty graft containers: most clinics use stainless or polypropylene specialty containers because they hold temperature better than plastic petri dishes. The container is part of the protocol, not an afterthought.

Written by
Editorial Team
Hair Transplant Source Editorial

The Hair Transplant Source editorial team produces independent, technique-level reference material for hair restoration clinicians and clinic operators. Articles are written by the team and, where the topic is clinical, reviewed by a named hair restoration surgeon before they are presented as reviewed clinical content.

  • Independent editorial line
  • Clinical articles reviewed by named surgeons
  • No paid editorial coverage

Related reading

Last reviewed: July 10, 2026. Content is educational only and does not constitute medical advice. See our methodology.